Amalgamated Bank Reduces Stock Position in agilon health, inc. (NYSE:AGL)

Amalgamated Bank trimmed its stake in shares of agilon health, inc. (NYSE:AGL) by 46.2% in the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 10,382 shares of the company’s stock after selling 8,921 shares during the period. Amalgamated Bank’s holdings in agilon health were worth $68,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in AGL. Capital International Investors raised its stake in agilon health by 84.7% during the 1st quarter. Capital International Investors now owns 20,197,932 shares of the company’s stock valued at $123,207,000 after buying an additional 9,263,296 shares during the last quarter. Capital World Investors increased its position in agilon health by 7.4% during the fourth quarter. Capital World Investors now owns 55,218,496 shares of the company’s stock valued at $692,992,000 after acquiring an additional 3,813,214 shares during the last quarter. Price T Rowe Associates Inc. MD lifted its holdings in agilon health by 46.0% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 10,139,886 shares of the company’s stock valued at $127,256,000 after acquiring an additional 3,195,087 shares during the period. Wellington Management Group LLP grew its stake in shares of agilon health by 2.9% during the 4th quarter. Wellington Management Group LLP now owns 42,510,030 shares of the company’s stock valued at $533,501,000 after purchasing an additional 1,191,253 shares during the period. Finally, Susquehanna Fundamental Investments LLC bought a new stake in shares of agilon health during the 1st quarter valued at about $2,975,000.

Insider Buying and Selling

In related news, CEO Steven Sell bought 20,000 shares of the company’s stock in a transaction that occurred on Thursday, September 12th. The shares were purchased at an average cost of $3.36 per share, with a total value of $67,200.00. Following the completion of the acquisition, the chief executive officer now directly owns 67,590 shares in the company, valued at $227,102.40. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 3.20% of the stock is currently owned by company insiders.

Analyst Ratings Changes

A number of research analysts have recently weighed in on the company. Evercore ISI lifted their price objective on agilon health from $5.50 to $7.00 and gave the company an “in-line” rating in a research report on Tuesday, July 9th. Royal Bank of Canada reaffirmed an “outperform” rating and set a $8.00 price target on shares of agilon health in a report on Wednesday, August 7th. Benchmark reiterated a “buy” rating and issued a $9.00 price target on shares of agilon health in a research report on Thursday, August 8th. Finally, Deutsche Bank Aktiengesellschaft lowered their target price on shares of agilon health from $5.00 to $4.00 and set a “hold” rating on the stock in a research note on Friday, August 9th. One analyst has rated the stock with a sell rating, fourteen have given a hold rating and four have issued a buy rating to the company. According to MarketBeat.com, the company has an average rating of “Hold” and a consensus price target of $8.57.

agilon health Price Performance

agilon health stock opened at $3.67 on Wednesday. The company has a debt-to-equity ratio of 0.04, a current ratio of 1.36 and a quick ratio of 1.36. The stock has a market cap of $1.51 billion, a price-to-earnings ratio of -5.24 and a beta of 0.54. The firm has a 50-day moving average of $4.71 and a two-hundred day moving average of $5.43. agilon health, inc. has a 1 year low of $3.07 and a 1 year high of $20.37.

agilon health (NYSE:AGL) last issued its quarterly earnings data on Tuesday, August 6th. The company reported ($0.07) earnings per share for the quarter, hitting analysts’ consensus estimates of ($0.07). The firm had revenue of $1.48 billion during the quarter, compared to analysts’ expectations of $1.56 billion. agilon health had a negative return on equity of 29.91% and a negative net margin of 5.57%. The firm’s quarterly revenue was up 38.7% on a year-over-year basis. During the same period in the prior year, the business posted ($0.04) EPS. On average, research analysts forecast that agilon health, inc. will post -0.32 earnings per share for the current year.

About agilon health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.